University Hospital Maastricht
Maastricht, 6202 AZ, Netherlands
NCT Number: NCT00396903
During the insertion of epidural catheters several complications can occur, including transient paraesthesia and inadvertent venous cannulation.
Reported incidences for paraesthesia vary widely between about 0.2% and 50% in different articles, depending on the catheter (catheter material, soft-tipped or firm-tipped catheter), the applied technique (lumbar or thoracic epidural anesthesia, depth of catheter insertion), the approach (midline or paramedian) and the included patients (obstetrical or non-obstetrical). Furthermore, the inconsistent definition of "paraesthesia" makes it difficult to compare the results of different studies. Paraesthesia are not supposed to lead to permanent neurological sequelea, but are unpleasant and perturbing sensations for the patient.
For inadvertent venous cannulation during epidural catheter placement, incidences between 1% and 14% have been reported. As for the paraesthesia rate, catheter material, technique, approach and included patients are determinants for the incidence of vessel puncture.
Main objective of this study is to determine the incidence of paraesthesia with this catheter.
Secondary objectives are to record
* the frequency of inadvertent venous cannulation * difficulties involved in insertion and removal of the catheter * data on additional complications * data for the evaluation of handling characteristics
Looking for future studies?
Notify Me18 year–75 year
All sexes
Observational
Maastricht, 6202 AZ, Netherlands
Study design
This study is a prospective, uncontrolled, open, non-randomised study ("Observational Study") with a CE-certified medical device.
Patients
Information and consent Information of the procedure and oral consent of epidural anaesthesia for the surgery is obtained as usual. Oral consent for data collection has to be obtained. No randomisation or blinding is performed and no non-standard procedures are necessary.
Inclusion criteria
100 patients scheduled for Epidural Anaesthesia will be included in this study. Eligible patients are ASA class I-III, between 18 and 75 years of age and are scheduled for EA, with or without general anaesthesia.
Exclusion criteria
Anamnestic exclusion criteria are all contraindications for epidural anaesthesia (e.g. neurological deficit, skin infection of the puncture site, diseases leading to neurological impairment such as diabetes, coagulation impairment). Non-competent and non-cooperative patients as well as pregnant and breast-feeding women are also to be excluded. Same applies for patients with medicament- and drug abuse or problems in communication or those participating in parallel in another clinical study with experimental drugs or devices.
Randomisation and Blinding No randomization is required. An independent observer who is not performing the epidural will record occurrence, incidence and intensity of paraesthesia.
Definition of the main and the secondary criteria
Main criteria
Secondary criteria
Concomitant parameters
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Maastricht University Medical Center
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07375823
Cervical Radicular Pain, Cervical Radiculopathy
Lefka, Cyprus
View Trial DetailsNCT07416006
Diode Laser Therapy, Hypesthesia
Samsun, Turkey (Türkiye)
View Trial DetailsNCT07350811
Leg Ulcer, Nervous System Diseases
Le Chesnay, France
View Trial DetailsNCT06906458
Interscalene Block, Nervous System Diseases
Ankara, Ankara, Çankaya, Turkey (Türkiye)
View Trial Details